Cambridge

Moderna's stock surged up to 160 percent after a melanoma vaccine trial succeeded, wiping out $5 billion in short bets, Bloomberg reports. The Cambridge biotech's rally, tied to a jointly developed vaccine with partner Merck aimed at preventing melanoma's return, was the day's biggest l…

Harvard University agreed to pay $53 million to settle lawsuits over a former morgue manager's theft of donated body parts, the biggest of several fresh entanglements for the Cambridge school this week. Reuters reported the settlement Tuesday, while the South China Morning Post reports …

Sanofi is laying off 229 Blueprint Medicines staffers and closing the company's Cambridge offices following its acquisition, according to a FiercePharma report. Kate Haviland, formerly Blueprint's CEO, has since taken the board chair role at GC Therapeutics, a Cambridge-based cell thera…